XRCC1 and endometrial cancer: In the TCGA dataset, it can be found that XRCC1 has the highest mutation rate in Uterine Corpus Endometrial Carcinoma samples, Cervical squamous cell carcinoma and endocervical adenocarcinoma has a relatively high mutation rate, and ovarian cancer has a low mutation rate, indicating that the mutation of this gene may lead to endometrial cancer and cervical cancer.